Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Multidisciplinary coordination across prescribing teams, nursing, laboratory medicine, finance, and infusion centers is crucial for gene therapy delivery in Duchenne muscular dystrophy (DMD).

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

In the complex process of producing a gene therapy, bioprocessors depend on ... To help quantify that delivery, Thermo Fisher developed its AAV genomic titer dPCR assay. Still, the company plans ...

Feb. 7, 2025 — A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 ...

When discussing challenges in gene therapy, delivery of the genetic payload is always at the top of the list. Whether discussing viral or nonviral gene delivery, challenges are present in every ...

and cost-effective than traditional directed evolution and rational design-based strategies. The study by Wu et al. is a great step forward in developing AI tools for the gene therapy field," says ...

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene ...

Chitra Kannabiran, PhD, Kallam Anji Reddy Molecular Genetics Laboratory, Hyderabad Eye Research Foundation, Champalimaud Translational Centre, LV Prasad Eye Institute, Hyderabad 500 034, India ...